Shopping Cart
- Remove All
- Your shopping cart is currently empty
Pramipexole (SND 919) is a selective dopamine receptor agonist used in the therapy of Parkinson disease. Pramipexole therapy is associated with a low rate of transient serum enzyme elevations during treatment but has not been implicated in cases of clinically apparent acute liver injury.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
500 mg | $42 | In Stock | |
1 mL x 10 mM (in DMSO) | $46 | In Stock |
Description | Pramipexole (SND 919) is a selective dopamine receptor agonist used in the therapy of Parkinson disease. Pramipexole therapy is associated with a low rate of transient serum enzyme elevations during treatment but has not been implicated in cases of clinically apparent acute liver injury. |
Targets&IC50 | D2S receptor:3.9 nM(Ki), D3 receptor:0.5 nM(Ki), D2L receptor:2.2 nM(Ki), D4 receptor:5.1 nM(Ki) |
Alias | SND 919 |
Molecular Weight | 211.33 |
Formula | C10H17N3S |
Cas No. | 104632-26-0 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 75 mg/mL (354.9 mM), Sonication is recommended. H2O: < 1 mg/mL (insoluble or slightly soluble) Ethanol: 39 mg/mL (184.5 mM) | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
Ethanol/DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.